Josep Villanueva
Papers
4
Total Citations
742
H-Index
4
About
Josep Villanueva is a pioneering researcher in the field of clinical proteomics, with a particular focus on serum peptidomics and biomarker discovery for cancer diagnostics. His work has fundamentally advanced our understanding of how proteolytically derived peptides circulating in human blood can serve as powerful indicators of disease, including solid tumors and metastatic cancers. Villanueva's most celebrated contribution, his 2004 paper on magnetic particle-assisted serum peptide profiling combined with MALDI-TOF mass spectrometry, has garnered an impressive 449 citations, establishing a robust technical framework for high-throughput serum analysis. Building on this, his 2006 study demonstrated that serum peptidome patterns could reliably distinguish metastatic thyroid carcinoma from healthy controls — findings unaffected by gender or age, lending significant clinical credibility to the approach (178 citations). His development of the Sequence-Specific Exopeptidase Activity Test (SSEAT) in 2007 introduced an innovative strategy for "functional" biomarker discovery by directly measuring enzyme activities in complex biological samples, rather than relying on surrogate markers. Together, his body of work has helped lay the groundwork for next-generation liquid biopsy approaches, making him a key figure in translational cancer research and proteomics methodology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4